Open Access

Lp(a): From CV risk marker to therapeutic target

Event: ESC Congress 2021 - The Digital Experience
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Sponsored by PACE-CME
Date: 28 August 2021
Time: 09:00 - 09:30

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

3 presentations in this session

Why focus on Lp(a) in cardiology?

Speaker: Professor N. Sattar (Glasgow, GB)
Thumbnail

Understanding the increased cardiovascular risk of high Lp(a) levels.

Speaker: Professor F. Kronenberg (Innsbruck, AT)
Thumbnail

Lp(a) as therapeutic target: Now and in the future.

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

3 speakers from this session

Professor Naveed Sattar

BHF Glasgow Cardiovascular Research Centre, Glasgow (United Kingdom of Great Britain & Northern Ireland)
30 presentations
2 followers

Professor Florian Kronenberg

Medical University of Innsbruck, Innsbruck (Austria)
1 presentation
0 follower

Professor Erik Stroes

Academic Medical Center of Amsterdam, Amsterdam (Netherlands (The))
17 presentations
0 follower

This platform is supported by

logo Novo Nordisk